注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Brainstorm Cell Therapeutics Inc是一家生物技術公司。該公司專注於開發和商業化用於治療神經退行性疾病的自體細胞療法,包括肌萎縮側索硬化症(ALS,也稱為 Lou Gehrig 病)、進行性多發性硬化症(PMS)、阿爾茨海默病(AD)等神經退行性疾病。NurOwn是其細胞治療平台,該平台利用細胞培養方法誘導自體骨髓間充質乾細胞 (MSCs) 分泌高水平的神經營養因子 (NTF),調節神經炎症和神經退行性疾病過程,促進神經元存活並改善神經功能。NurOwn已完成其III期ALS和II期PMS臨床試驗。其全資子公司BrainStorm Cell Therapeutics Ltd擁有將其NurOwn技術商業化的權利。其他子公司包括Advanced Cell Therapies Ltd和另外兩家。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Jacob Ahron Frenkel | 78 | 2007 | Independent Chairman of the Board |
Andrew Hill Card | 73 | 2011 | Member of Business Advisory Board |
Rasheda Ali | - | 2007 | Member of Business Advisory Board |
Irit Arbel | 63 | 2004 | Co-Founder & Independent Vice Chair of the Board |
Jerold Chun | - | 2018 | Chairman of Scientific Advisory Board |
Nir Naor | 49 | 2023 | Independent Director |
Stanley H. Appel | 90 | - | Member of Scientific Advisory Board |
Menghisteab Bairu | 62 | 2021 | Independent Director |
Amit Bar-Or | - | - | Member of Scientific Advisory Board |
Ralph Z. Kern | 65 | 2017 | Member of Scientific Advisory Board |
Anthony J. Polverino | 60 | 2018 | Independent Director |
Uri Yablonka | 47 | 2014 | Executive VP, Chief Business Officer, Secretary & Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核